Redefining the Role of Resection Weight Prediction in Reduction Mammaplasty and Breaking the "One-Scale-Fits-All" Paradigm.

Plastic and reconstructive surgery 2019 Vol.144(1) p. 18e-27e

Boukovalas S, Padilla PL, Spratt H, Tran JP, Li RT, Boson AL, Howland N, Phillips LG

관련 도메인

Abstract

[BACKGROUND] Reduction mammaplasty is a highly effective procedure for treatment of symptomatic macromastia. Prediction of resection weight is important for the surgeon and the patient, but none of the current prediction models is widely accepted. Insurance carriers are arbitrarily using resection weight to determine medical necessity, despite published literature supporting that resection weight does not correlate with symptomatic relief. What is the most accurate method of predicting resection weight and what is its role in breast reduction surgery?

[METHODS] The authors conducted a retrospective review of patients who underwent reduction mammaplasty at a single institution from 2012 to 2017. A senior biostatistician performed multiple regression analysis to identify predictors of resection weight, and linear regression models were created to compare each of the established prediction scales to actual resected weight. Patient outcomes were evaluated.

[RESULTS] Three-hundred fourteen patients were included. A new prediction model was created. The Galveston scale performed the best (R = 0.73; p < 0.001), whereas the Schnur scale performed the worst (R = 0.43; p < 0.001). The Appel and Descamps scales had variable performance in different subcategories of body mass index and menopausal status (p < 0.01). Internal validation confirmed the Galveston scale's best predictive value; 38.6 percent and 28.9 percent of actual breast resection weights were below Schnur prediction and 500-g minimum, respectively, yet 97 percent of patients reported symptomatic improvement or relief.

[CONCLUSIONS] The authors recommend a patient-specific and surgeon-specific approach for prediction of resection weight in breast reduction. The Galveston scale fits the best for older patients with higher body mass indices and breasts requiring large resections. Medical necessity decisions should be based on patient symptoms, physical examination, and the physician's clinical judgment.

[CLINICAL QUESTION/LEVEL OF EVIDENCE] Diagnostic, IV.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 mammaplasty 유방성형술 dict 3
해부 breast 유방 dict 3
시술 breast reduction 유방성형술 dict 2
해부 breasts scispacy 1
약물 [BACKGROUND] scispacy 1
약물 [RESULTS] Three-hundred scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 macromastia C0020565
Hypertrophy of Breast
scispacy 1
질환 fits C0036572
Seizures
scispacy 1
질환 breasts C0006141
Breast
scispacy 1
기타 patient scispacy 1
기타 patients scispacy 1

MeSH Terms

Adult; Body Mass Index; Body Weight; Breast; Female; Humans; Hypertrophy; Insurance, Health, Reimbursement; Mammaplasty; Middle Aged; Organ Size; Regression Analysis; Retrospective Studies

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문